Back to top

A qualitative study that took place in Malawi, South Africa, Uganda and Zimbabwe to understand community belief systems and attitudes that may affect women’s perceptions about and potential interest in using the monthly dapivirine vaginal ring or daily PrEP during pregnancy and breastfeeding. The study involved group discussions with women, male partners and mothers and mothers-in-law of pregnant and breastfeeding women and interviews with community leaders, healthcare providers, midwives and traditional birth attendants, among others. The results, expected in mid-2020, will help inform implementation of the DELIVER (MTN-042) and B-PROTECTED (MTN-043) studies in pregnant women and breastfeeding women, respectively.

 

The DELIVER and B-PROTECTED Studies: Preventing HIV in Pregnant and Breastfeeding Women
10-February-2020

Spotlight on MTN-041 

See Also

MTN-041 Protocol

 

MTN-041 Study Page